Preventive effect of Bushimatsu and Keishikajubutou on peripheral neurotoxicity of Oxaliplatin(L-OHP) therapy: a phase II clinical study.
- Conditions
- colorectal cancer
- Registration Number
- JPRN-UMIN000031159
- Lead Sponsor
- Wakayama Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 32
Not provided
(1) Patients with resistance to taking medicine for traditional Chinese medicine (2) Patients with pre-treatment history of oxaliplatin (3) Patients with duplicated active cancer (4) Patients with severe dysesthesia or dysesthesia with dysfunction (5) Patients with a history of severe drug hypersensitivity (6) Patients with clinically problematic infection (7) Patients in which it was judged that registration in this study was difficult due to clinically problematic mental / neurological diseases (8) Patients with any of the following complications i) diabetes with poor control ii) hypertension with poor control iii) interstitial pneumonia or pulmonary fibrosis iv) intestinal palsy or intestinal obstruction v) clinically problematic heart disease (9) Other patients that the doctor in charge judged unsuitable for safely carrying out this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety and efficacy of Keishi Kamisukutou (TJ - 18) + bushi-matsu (TJ - 3023) for oxaliplatin-induced peripheral neuropathy
- Secondary Outcome Measures
Name Time Method